In neurodegenerative diseases (such as Alzheimer’s or Parkinson’s), some curcumin-loaded nanoparticles can cross the blood–brain barrier and help in the reduction in the inherent side effects or even reduce the β-amyloid plaque. This evidence concerns the gene PPIB and Parkinson disease.